These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27378623)

  • 1. Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats.
    Pastryk JE; Rusek M; Bełtowski J
    Chem Biol Interact; 2016 Nov; 259(Pt B):407-412. PubMed ID: 27378623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
    Rusek M; Pastryk JE; Bełtowski J
    Chem Biol Interact; 2016 Nov; 259(Pt B):401-406. PubMed ID: 27387541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
    Gałczyński K; Bełtowski J; Nowakowski Ł; Vasilevska D; Rechberger T; Semczuk A
    Tumour Biol; 2018 Sep; 40(9):1010428318797869. PubMed ID: 30178714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
    Ferré N; Feliu A; García-Heredia A; Marsillach J; París N; Zaragoza-Jordana M; Mackness B; Mackness M; Escribano J; Closa-Monasterolo R; Joven J; Camps J
    Clin Biochem; 2013 Dec; 46(18):1830-6. PubMed ID: 24028901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes.
    Bayrak A; Bayrak T; Demirpençe E; Kılınç K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):49-55. PubMed ID: 21123122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease.
    Parada-Turska J; Wójcicka G; Beltowski J
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of saquinavir, atazanavir, and ritonavir in a twice-daily boosted double-protease inhibitor regimen.
    von Hentig N; Müller A; Rottmann C; Wolf T; Lutz T; Klauke S; Kurowski M; Oertel B; Dauer B; Harder S; Staszewski S
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1431-9. PubMed ID: 17296738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paraoxonase 1 (PON1), platelet-activating factor acetylohydrolase (PAF-AH) and dimethylarginine dimethylaminohydrolase (DDAH) activity in the metformin treated normal and diabetic rats.
    Wójcicka G; Jamroz-Wiśniewska A; Czechowska G; Korolczuk A; Marciniak S; Bełtowski J
    Eur J Pharmacol; 2016 Oct; 789():187-194. PubMed ID: 27450486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment durability, effectiveness, and safety with atazanavir/ritonavir-based HAART regimen in treatment-naïve HIV-infected patients.
    Tremblay C; Trottier B; Rachlis A; Baril JG; Loutfy M; Lalonde R; Sampalis JS; Boulerice F
    HIV Clin Trials; 2011; 12(3):151-60. PubMed ID: 21684855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
    Mallolas J; Blanco J; Labarga P; Vergara A; Ocampo A; Sarasa M; Arnedo M; López-Púa Y; García J; Juega J; Guelar A; Terrón A; Dalmau D; García I; Zárraga M; Martínez E; Carné X; Pumarola T; Escayola R; Gatell J
    HIV Med; 2007 May; 8(4):226-33. PubMed ID: 17461850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
    Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
    Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase 1 and homocysteine metabolism.
    Perła-Kaján J; Jakubowski H
    Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human paraoxonase-1 activity is related to the number of CD4+ T-cells and is restored by antiretroviral therapy in HIV-1-infected individuals.
    Maselli LM; da Cunha J; Gutierrez EB; Maranhão RC; Spada C; Bydlowski SP
    Dis Markers; 2014; 2014():480201. PubMed ID: 24719500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of paraoxonase 1 and lipid profile in healthy children.
    Sumegová K; Nagyová Z; Waczulíková I; Zitnanová I; Duracková Z
    Physiol Res; 2007; 56(3):351-357. PubMed ID: 16792468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
    Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine.
    Bolayirli IM; Aslan M; Balci H; Altug T; Hacibekiroglu M; Seven A
    Life Sci; 2007 Jun; 81(2):121-7. PubMed ID: 17532348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats.
    Shibata N; Kageyama M; Kishida T; Kimura K; Yoshikawa Y; Kuwahara T; Toh J; Shirasaka T; Takada K
    Biopharm Drug Dispos; 2003 Nov; 24(8):335-44. PubMed ID: 14595702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
    Perla-Kaján J; Jakubowski H
    FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.
    Tomazic J; Karner P; Vidmar L; Maticic M; Sharma PM; Janez A
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):99-105. PubMed ID: 16200335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.